News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vitro Diagnostics (VODG) Appoints Prominent Denver Investment Banker to Its Board of Directors



2/23/2010 10:44:35 AM

GOLDEN, Colo.--(BUSINESS WIRE)--Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, announced the appointment of Richard Huebner to its Board of Directors. Mr. Huebner is a Senior Managing Partner of GVC Capital (formerly Bathgate Capital) a Denver-based investment bank focused on microcap companies. Mr. Huebner has an extensive, 30-year background in the securities industry. He received a B.A. in Economics and Business Administration from Hastings College and a J.D. from the University of Nebraska. He was previously General Counsel for Hanifen, Imhoff, Inc. from 1984 to 1995 where he served in numerous positions. Following the sale of Hanifen, Imhoff to Fiserv, Inc. in 1997, he continued with that firm. He joined Bathgate Capital in 2001. Mr. Huebner joins existing Board members, Dr. Jim Musick, Vitro’s President and CEO, who directed the establishment of the Company in its present form and Erik Van Horn, BSChE, who is presently employed by a leading biotechnology firm as a specialist in the manufacture of human biotherapeutics.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES